Morgan Stanley Bitcoin ETF Adds $50.6M as Inflows Strengthen
Morgan Stanley’s MSBT spot Bitcoin ETF bought about 642 BTC worth $50.6 million through Coinbase Prime during two weeks in September 2026. Since its April launch, the Morgan Stanley Bitcoin ETF has attracted more than $538 million in cumulative net inflows and recorded only one daily outflow of $5.26 million. Its net assets were estimated at between $586 million and $635 million by mid-September.
The latest purchases extend a broader trend of demand for regulated Bitcoin investment products. Most MSBT inflows have come from self-directed clients rather than Morgan Stanley financial advisers. The fund charges a 0.14% expense ratio, uses Coinbase Custody and BNY Mellon, and tracks the CoinDesk Bitcoin Benchmark Rate.
US spot Bitcoin ETFs recorded $433 million in net inflows on 18 September, while spot Ethereum ETFs attracted $144 million. Strong Bitcoin ETF inflows may support BTC liquidity and investor confidence, but traders should note that ETF flows remain sensitive to Bitcoin’s price trend, macroeconomic conditions and broader risk appetite.
Bullish
The news is moderately bullish for BTC because MSBT purchased approximately 642 BTC, while cumulative inflows into the fund exceeded $538 million and US spot Bitcoin ETFs attracted a further $433 million in one day. These flows suggest sustained demand from institutional and self-directed investors and may provide additional liquidity and buying support.
In the short term, traders may interpret the purchases as a positive sentiment signal, particularly if ETF inflows continue alongside stable or rising Bitcoin prices. However, ETF demand does not guarantee immediate price gains. Flows can reverse during periods of risk aversion, macroeconomic stress or Bitcoin weakness, and the reported purchases may already be reflected in market prices.
Over the longer term, continued adoption of regulated Bitcoin ETFs could broaden market access and strengthen institutional participation. The limited outflow history of MSBT is supportive, but its relatively new track record and dependence on wider market conditions mean the price impact is more likely to be supportive than decisive.